CO6450678A2 - Proceso para preparar compuestos antivirales - Google Patents
Proceso para preparar compuestos antiviralesInfo
- Publication number
- CO6450678A2 CO6450678A2 CO11123197A CO11123197A CO6450678A2 CO 6450678 A2 CO6450678 A2 CO 6450678A2 CO 11123197 A CO11123197 A CO 11123197A CO 11123197 A CO11123197 A CO 11123197A CO 6450678 A2 CO6450678 A2 CO 6450678A2
- Authority
- CO
- Colombia
- Prior art keywords
- antiviral compounds
- salts
- compound
- prepare antiviral
- prepare
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
- C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
- C07C303/36—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids
- C07C303/40—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids by reactions not involving the formation of sulfonamide groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
- C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C311/08—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic System
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/0803—Compounds with Si-C or Si-Si linkages
- C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
- C07F7/0812—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring
Abstract
(a) Procesos para preparar un compuesto y sales del mismo que, entre otros, son de utilidad para inhibir al virus de la hepatitis C (HCV); (b) intermediarios de utilidad para la preparación del compuesto y las sales; (c) composiciones farmacéuticas que comprenden al compuesto o las sales; y (d) métodos para usar de dichas composiciones.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16270509P | 2009-03-24 | 2009-03-24 | |
US31671310P | 2010-03-23 | 2010-03-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
CO6450678A2 true CO6450678A2 (es) | 2012-05-31 |
Family
ID=42136100
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO11123197A CO6450678A2 (es) | 2009-03-24 | 2011-09-21 | Proceso para preparar compuestos antivirales |
Country Status (24)
Country | Link |
---|---|
EP (1) | EP2411372B1 (es) |
JP (1) | JP5744003B2 (es) |
KR (1) | KR101665955B1 (es) |
CN (1) | CN102361858B (es) |
AU (1) | AU2010229975B2 (es) |
BR (1) | BRPI1009854A2 (es) |
CA (1) | CA2753825C (es) |
CL (1) | CL2011002278A1 (es) |
CO (1) | CO6450678A2 (es) |
CR (1) | CR20110524A (es) |
DO (1) | DOP2011000297A (es) |
EC (1) | ECSP11011415A (es) |
ES (1) | ES2488821T3 (es) |
GT (1) | GT201100241A (es) |
HK (1) | HK1166798A1 (es) |
IL (1) | IL214858A (es) |
MX (1) | MX2011010049A (es) |
MY (1) | MY169288A (es) |
NZ (1) | NZ594923A (es) |
PE (1) | PE20120519A1 (es) |
RU (1) | RU2524573C2 (es) |
SG (1) | SG174211A1 (es) |
WO (1) | WO2010111348A1 (es) |
ZA (1) | ZA201106511B (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9255074B2 (en) | 2010-07-16 | 2016-02-09 | Abbvie Inc. | Process for preparing antiviral compounds |
MY167881A (en) | 2010-07-16 | 2018-09-26 | Abbvie Bahamas Ltd | Process for preparing antiviral compounds |
MX338725B (es) | 2010-07-16 | 2016-04-28 | Abbvie Bahamas Ltd | Ligando de fosfina para reacciones cataliticas. |
US8975443B2 (en) | 2010-07-16 | 2015-03-10 | Abbvie Inc. | Phosphine ligands for catalytic reactions |
CA2829768A1 (en) * | 2011-03-18 | 2012-09-27 | Abbvie Inc. | Formulations of phenyl uracil compounds |
US20160375017A1 (en) | 2015-06-26 | 2016-12-29 | Abbvie Inc. | Solid Pharmaceutical Compositions for Treating HCV |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1219626B1 (en) * | 1999-09-20 | 2005-06-01 | Fuji Photo Film Co., Ltd. | Compounds for fluorescence labeling |
DK1218401T3 (da) * | 1999-09-22 | 2004-10-04 | Aventis Pharma Gmbh | 4-Benzylaminoquinolin-konjugat med galdesyre og deres heteroanaloger, fremgangsmåde til deres fremstilling, lægemidler indeholdende disse forbindelser og deres anvendelse |
DE10051981A1 (de) * | 2000-10-20 | 2002-05-02 | Bayer Ag | Substituierte Phenyluracile |
AU2007266915A1 (en) | 2006-05-30 | 2007-12-06 | Arrow Therapeutics Limited | Biphenyl derivatives and their use in treating hepatitis C |
EP2548873A1 (en) * | 2007-09-17 | 2013-01-23 | Abbott Laboratories | N-phenyl-dioxo-hydropyrimidines useful as hepatitis c virus (hcv) inhibitors |
WO2009039127A1 (en) * | 2007-09-17 | 2009-03-26 | Abbott Laboratories | Uracil or thymine derivative for treating hepatitis c |
JP2011528686A (ja) * | 2008-07-23 | 2011-11-24 | エフ.ホフマン−ラ ロシュ アーゲー | ヘテロ環式抗ウイルス性化合物 |
-
2010
- 2010-03-24 EP EP10711968.7A patent/EP2411372B1/en active Active
- 2010-03-24 SG SG2011063179A patent/SG174211A1/en unknown
- 2010-03-24 CN CN201080013374.7A patent/CN102361858B/zh active Active
- 2010-03-24 ES ES10711968.7T patent/ES2488821T3/es active Active
- 2010-03-24 MX MX2011010049A patent/MX2011010049A/es active IP Right Grant
- 2010-03-24 WO PCT/US2010/028433 patent/WO2010111348A1/en active Application Filing
- 2010-03-24 CA CA2753825A patent/CA2753825C/en active Active
- 2010-03-24 BR BRPI1009854-2A patent/BRPI1009854A2/pt not_active Application Discontinuation
- 2010-03-24 JP JP2012502196A patent/JP5744003B2/ja active Active
- 2010-03-24 RU RU2011142757/04A patent/RU2524573C2/ru active
- 2010-03-24 AU AU2010229975A patent/AU2010229975B2/en active Active
- 2010-03-24 PE PE2011001686A patent/PE20120519A1/es active IP Right Grant
- 2010-03-24 NZ NZ594923A patent/NZ594923A/xx unknown
- 2010-03-24 KR KR1020117024825A patent/KR101665955B1/ko active IP Right Grant
- 2010-03-24 MY MYPI2011004471A patent/MY169288A/en unknown
-
2011
- 2011-08-24 EC EC2011011415A patent/ECSP11011415A/es unknown
- 2011-08-28 IL IL214858A patent/IL214858A/en active IP Right Grant
- 2011-09-06 ZA ZA2011/06511A patent/ZA201106511B/en unknown
- 2011-09-14 CL CL2011002278A patent/CL2011002278A1/es unknown
- 2011-09-20 GT GT201100241A patent/GT201100241A/es unknown
- 2011-09-21 CO CO11123197A patent/CO6450678A2/es active IP Right Grant
- 2011-09-23 DO DO2011000297A patent/DOP2011000297A/es unknown
- 2011-10-04 CR CR20110524A patent/CR20110524A/es unknown
-
2012
- 2012-08-01 HK HK12107568.3A patent/HK1166798A1/xx unknown
Also Published As
Publication number | Publication date |
---|---|
IL214858A0 (en) | 2011-11-30 |
CL2011002278A1 (es) | 2012-03-09 |
CR20110524A (es) | 2012-01-19 |
JP2012521990A (ja) | 2012-09-20 |
EP2411372A1 (en) | 2012-02-01 |
RU2011142757A (ru) | 2013-04-27 |
CN102361858B (zh) | 2014-07-23 |
EP2411372B1 (en) | 2014-07-23 |
JP5744003B2 (ja) | 2015-07-01 |
NZ594923A (en) | 2013-11-29 |
AU2010229975A1 (en) | 2011-09-29 |
DOP2011000297A (es) | 2011-10-15 |
KR20110137372A (ko) | 2011-12-22 |
CA2753825C (en) | 2017-10-17 |
GT201100241A (es) | 2015-08-19 |
CN102361858A (zh) | 2012-02-22 |
RU2524573C2 (ru) | 2014-07-27 |
KR101665955B1 (ko) | 2016-10-13 |
IL214858A (en) | 2015-05-31 |
MY169288A (en) | 2019-03-21 |
AU2010229975B2 (en) | 2015-05-21 |
BRPI1009854A2 (pt) | 2015-08-25 |
ES2488821T3 (es) | 2014-08-29 |
ECSP11011415A (es) | 2011-11-30 |
WO2010111348A1 (en) | 2010-09-30 |
HK1166798A1 (en) | 2012-11-09 |
ZA201106511B (en) | 2012-05-30 |
PE20120519A1 (es) | 2012-06-03 |
MX2011010049A (es) | 2011-10-11 |
CA2753825A1 (en) | 2010-09-30 |
SG174211A1 (en) | 2011-10-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ECSP13012438A (es) | Proceso para preparar compuestos antivirales | |
CR20170316A (es) | Compuestos de pirazina para el tratamiento de enfermedades infecciosas | |
CR20190504A (es) | COMPUESTO DE AMIDA (Divisional 2015-0454) | |
CO6561788A2 (es) | Inhibidores del virus de la hepatitis c | |
ECSP12011684A (es) | Inhibidores de los virus flaviviridae. | |
DOP2010000084A (es) | Derivado de uracilo o timina para el tratamiento de hepatitis c | |
CL2011002830A1 (es) | Compuestos derivados de haloalquil heteroaril benzamidas; composicion farmaceutica uso de la composicion en el tratamiento de una infeccion viral, tal como el virus de la hepatitis b y c. | |
PE20230684A1 (es) | Analogos de carba-nucleosidos sustituidos con 2'-fluoro como inhibidores de la arn polimerasa | |
CL2014000612A1 (es) | Compuestos derivados de prolinas macrociclicas, inhibidores de las proteasas de serina del virus de la hepatitis c (vhc); composicion farmaceutica que los comprende; y su uso para tratar una infeccion viral tal como la infeccion por el virus de la hepatitis c (vhc). | |
DOP2013000277A (es) | 4-aril-n-fenil-1,3,5-triazin-2-aminas que contienen un grupo sulfoximina | |
ECSP11011310A (es) | Análogos carba - nucleósido para tratamiento antiviral | |
CO6761335A2 (es) | Inhibidores del virus de la hepatitis c | |
UY34066A (es) | Inhibidores del virus de la hepatitis c | |
ECSP14013189A (es) | Inhibidores de la replicación de los virus de la gripe | |
CO6561783A2 (es) | Inhibidores del virus flaviviridae | |
CO6361922A2 (es) | Inhibidores del virus de la hepatitis c | |
CO6430431A2 (es) | Inhibidores del virus de la hepatitis c | |
CR20110524A (es) | Proceso para preparar compuestos antivirales | |
BR112014010401A8 (pt) | Inibidores do vírus da hepatite c rod-like que contêm o fragmento {2-[4-(bifenil-4-il)-1h-imidazo-2-il] pirrolidina-1-carbonilmetil}amina | |
CL2012002362A1 (es) | Sales cristalinas de trometamina y de colina de un compuesto derivado de 2-tiazolil-4-quinolinil-oxi; composicion farmaceutica que las comprende, utiles para el tratamiento de la infeccion por el virus de la hepatitis c. | |
DOP2014000034A (es) | Compuestos de benzofurano para su uso en el tratamiento de infecciones por el virus de hepatitis c (hcv) | |
BR112014013972A2 (pt) | inibidores de hcv nssa | |
CO6321288A2 (es) | Sales de compuestos inhibidores de vih | |
AR086987A1 (es) | 1-piperazino-3-fenil-indanos deuterados para el tratamiento de esquizofrenia | |
MX360161B (es) | Proceso para preparar compuestos antiviricos. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Application granted |